Sunapto will be a start-up Limited Liability Company (LLC) located in MidWest, USA. Sunapto will manufacture and market the MedCabinet automatic pill dispenser, targeting the 65 and over market segments. Initial market research has been completed and this business plan will serve as the framework for bringing their product to market.
Sunapto is in the development stage and its proposed operations are subject to all the risks inherent in the establishment of a new business enterprise, including the absence of an operating history. The likelihood of Sunapto’s success must be considered in light of the problems, expenses, difficulties, complications and delays frequently encountered in connection with the formation of a new business, and the competitive and regulatory environment in which Sunapto will operate. Although forecast revenues and expenses are set forth in this Plan, the actual amounts may vary substantially from those projected and no assurance can be made that the results forecasted in this Plan will be achieved.
2.1 Start-up Summary
Sunapto’s start-up costs are expected to be minimal. They will be mostly stationery, legal costs, and expenses associated with opening their first office. The start-up costs are to be financed by direct owner investment. The assumptions are shown in the Start-up Table.
|Research and Development||$0|
|Total Start-up Expenses||$2,713|
|Other Current Assets||$0|
|Start-up Expenses to Fund||$2,713|
|Start-up Assets to Fund||$470,000|
|Total Funding Required||$472,713|
|Non-cash Assets from Start-up||$0|
|Cash Requirements from Start-up||$470,000|
|Additional Cash Raised||$0|
|Cash Balance on Starting Date||$470,000|
|Liabilities and Capital|
|Accounts Payable (Outstanding Bills)||$0|
|Other Current Liabilities (interest-free)||$0|
|John P. Brush||$2,713|
|Round 1 Investors||$420,000|
|Additional Investment Requirement||$0|
|Total Planned Investment||$472,713|
|Loss at Start-up (Start-up Expenses)||($2,713)|
|Total Capital and Liabilities||$470,000|
2.2 Company Ownership
It is anticipated that Sunapto will be structured as an LLC in MidWest, USA. Ownership will be distributed amongst the founding partners. The founders intend to sell limited ownership to outside private investors in external financing rounds.
2.3 Company Locations and Facilities
Sunapto is presently operated out of the home of the founder. Relocation to office space in the greater MidWest, USA area is anticipated at the realization of this business plan. Initially, the office space will be small to serve management of marketing functions, sales/ordering processing and technical development. As Sunapto adds employees, they will take on additional office space. Sunapto expects that space will be available in the future location.
Sunapto will conduct a search for a contract manufacturer for the MedCabinet. The contract manufacturer will initially handle distribution. Orders will be drop shipped from the plant. This eliminates the need to invest in distribution space at the outset.